Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;21(1):60-68.
doi: 10.1038/s41397-020-0177-y. Epub 2020 Jul 23.

Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China

Yuanwei Liu  1 , Haiyue Li  1 , Keqing Cao  1 , Jianfeng Liu  1 , Yao Sun  1 , Jiamin Wu  1 , Zichao Xiong  1 , Fanglin Niu  1 , Jing Li  1 , Tianbo Jin  2   3
Affiliations

Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China

Yuanwei Liu et al. Pharmacogenomics J. 2021 Feb.

Abstract

Drug gene polymorphisms are strongly associated with disease. Previous studies have shown that the frequency of drug genes varies in different populations. At present, there are no reports about the polymorphism of the drug genome in the Zhuang population in southern China. This study conducted a pharmacogenomics study on the Zhuang population in southern China. Therefore, we conducted genotyping on 105 Zhuang samples, and compared the genotyping results with those of other 11 ethnic groups after statistical analysis. Our results show that, compared with the 11 populations in the HapMap data set, the differences between the CYP2E1 rs2070676 and CYP2D6 rs1065852 of the Zhuang nationality are the largest. This study fills in the blank of the drug genome information of the Zhuang nationality in southern China. The two sites of Rs2070676 (CYP2E1) and rs1065852 (CYP2D6) provide a reliable basis for the prediction of the efficacy of certain drugs. Its main purpose is to provide theoretical basis for safe drug use in the Zhuang region of southern China.

PubMed Disclaimer

References

    1. Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenom J. 2005;5:6–13. - DOI
    1. Jin T, Shi X, Li W, Wang H, Tian F, Kang L. Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China. BMC Genet. 2016;17:70. - DOI
    1. He Y, Yang H, Geng T, Feng T, Yuan D, Kang L, et al. Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China. Int J Clin Exp Pathol. 2015;8:13293. - PubMed - PMC
    1. Jin T, Zhao R, Shi X, He N, He X, Ouyang Y, et al. Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China’s Shaanxi province. Environ Toxicol Pharmacol. 2016;46:27–35. - DOI
    1. Szekanecz Z, Meskó B, Poliska S, Váncsa A, Szamosi S, Végh E, et al. Pharmacogenetics and pharmacogenomics in rheumatology. High Blood Press Cardiovasc Prev Off J Ital Soc Hypertens. 2013;56:325–33.

Substances